Allergy Therapeutics (AGY) Stock Chart & Stock Price History GBX 6.50 0.00 (0.00%) As of 04/25/2025 11:57 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock Allergy Therapeutics Stock Price Performance 5 Day Performance+12.07%1 Month Performance+5.59%3 Month Performance-13.33%6 Month Performance+22.64%Year-To-Date Performance-0.38%1 Year Performance+128.07% Receive AGY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address AGY Stock Chart for Saturday, April, 26, 2025 AGY Chart by TradingView Allergy Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2025GBX 6.50GBX 6.50GBX 6.65GBX 6.17898,699 shs£319.48 million04/24/2025GBX 6.45GBX 6.50+0.78%GBX 6.90GBX 6.06818,339 shs£319.48 million04/23/2025GBX 6.30GBX 6.45+2.38%GBX 6.45GBX 5.71608,860 shs£317.02 million04/22/2025GBX 5.80GBX 6.30+8.62%GBX 6.35GBX 5.55318,408 shs£309.65 million04/21/2025GBX 5.80GBX 5.80GBX 5.80GBX 5.51277,174 shs£285.07 million04/18/2025GBX 5.80GBX 5.80GBX 5.80GBX 5.51277,174 shs£285.07 million04/17/2025GBX 5.70GBX 5.80+1.75%GBX 5.80GBX 5.51277,174 shs£285.07 million04/16/2025GBX 5.70GBX 5.70GBX 6GBX 5.51161,353 shs£280.16 million04/15/2025GBX 5.70GBX 5.70GBX 6GBX 5.50136,831 shs£280.16 million04/14/2025GBX 5.40GBX 5.70+5.56%GBX 6GBX 5.301.25 million shs£280.16 million Get the Latest News and Ratings for AGY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/11/2025GBX 5.42GBX 5.40-0.37%GBX 5.70GBX 51.73 million shs£265.41 million04/10/2025GBX 5.75GBX 5.42-5.74%GBX 5.90GBX 5387,751 shs£266.40 million04/09/2025GBX 5.70GBX 5.75+0.88%GBX 5.90GBX 5102,090 shs£282.62 million04/09/2025GBX 5.70GBX 5.75+0.88%GBX 5.90GBX 5102,090 shs£282.62 million04/08/2025GBX 5.45GBX 5.70+4.59%GBX 6GBX 5.281.22 million shs£280.16 million04/08/2025GBX 5.45GBX 5.70+4.59%GBX 6GBX 5.281.22 million shs£280.16 million04/07/2025GBX 5.62GBX 5.45-3.06%GBX 6.45GBX 5815,217 shs£267.87 million04/04/2025GBX 6.25GBX 5.62-10.05%GBX 6.50GBX 5.62889,672 shs£276.33 million04/03/2025GBX 6.40GBX 6.25-2.34%GBX 6.45GBX 5.63479,832 shs£307.19 million04/02/2025GBX 6.45GBX 6.40-0.78%GBX 6.45GBX 5.50327,467 shs£314.56 million04/01/2025GBX 6.30GBX 6.45+2.38%GBX 6.45GBX 5.70119,259 shs£317.02 million03/31/2025GBX 6.48GBX 6.30-2.78%GBX 6.75GBX 5.63358,988 shs£309.65 million03/28/2025GBX 6.27GBX 6.48+3.38%GBX 6.60GBX 6.48302,962 shs£318.50 million03/27/2025GBX 6GBX 6.27+4.47%GBX 6.87GBX 6.27744,645 shs£308.08 million03/26/2025GBX 6.16GBX 6-2.53%GBX 6.90GBX 6224,317 shs£294.90 million03/25/2025GBX 6.80GBX 6.16-9.47%GBX 7GBX 6536,935 shs£302.57 million03/24/2025GBX 6.80GBX 6.80GBX 6.80GBX 6.07361,656 shs£334.23 million Related Companies INDV Stock Chart APH Stock Chart ANCR Stock Chart VLG Stock Chart EAH Stock Chart STX Stock Chart PXS Stock Chart RGT Stock Chart CEL Stock Chart N4P Stock Chart Receive AGY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:AGY) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allergy Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Allergy Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AGY Stock Free AGY Stock Alerts